These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 194776)

  • 1. Serum migration inhibitory activity in patients with infectious diseases and various neoplasia.
    Bruley-Rosset M; Botto HG; Goutner A
    Eur J Cancer (1965); 1977; 13(4-5):325-7. PubMed ID: 194776
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of delayed hypersensitivity and leukocyte migration inhibition factor in the serum of cancer patients.
    Botto HG; Gauthier H; Pouillart P; Bruley-Rosset M; Huguenin P
    Eur J Cancer (1965); 1977; 13(4-5):329-32. PubMed ID: 194777
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum-migration-inhibitory activity in children with acute infectious mononucleosis.
    Bertotto A; Caprino D; Vaccaro R; Sonaglia F
    Clin Immunol Immunopathol; 1981 Jun; 19(3):314-8. PubMed ID: 7018770
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.
    Lai PK; Mackay-Scollay EM; Fimmel PJ; Alpers MP; Keast D
    Nature; 1974 Dec; 252(5484):608-10. PubMed ID: 4372559
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
    Wolberg WH
    Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of migration inhibitory factor (MIF) by human leukocytes following exposure to Epstein-Barr virus.
    Wilson GL; Young BG
    Cell Immunol; 1978 Jun; 38(1):147-56. PubMed ID: 208782
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of migration inhibition techniques in tumor immunology.
    Szigeti R
    Adv Cancer Res; 1985; 43():241-305. PubMed ID: 2986429
    [No Abstract]   [Full Text] [Related]  

  • 8. Abrogation of cell-mediated immunity by a serum blocking factor isolated from patients with infectious mononucleosis.
    Wainwright WH; Veltri RW; Sprinkle PM
    J Infect Dis; 1979 Jul; 140(1):22-32. PubMed ID: 88489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization to tumour-associated antigens in human breast carcinoma.
    Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
    Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic studies in infectious mononucleosis in children].
    Timár L; Koller M; Szigeti R; Budai J; Kuti D
    Orv Hetil; 1982 Oct; 123(44):2709-12. PubMed ID: 7145432
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parameters of cellular immunity in subjects with bronchial squamous cell tumors].
    Vietti Ramus G; Tartaglino B; Cesano L; Revello F; Barbalonga A
    Minerva Med; 1983 Apr; 74(16):879-87. PubMed ID: 6601781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular immunity in infectious mononucleosis - a case report].
    Bojić I; Ciko M; Lilić D
    Med Pregl; 1981; 34(11-12):521-4. PubMed ID: 7341927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity to human pulmonary neoplasms.
    Vose BM; Moore M; Jack GD
    Int J Cancer; 1975 Feb; 15(2):308-20. PubMed ID: 1126760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of leukocyte migration inhibition test in studying allergy to rifampicin].
    Janicka G
    Pol Tyg Lek; 1976 Jan; 31(1):13-4. PubMed ID: 765975
    [No Abstract]   [Full Text] [Related]  

  • 16. Similarity of migration inhibitory factor(s) produced by human lymphoid cell line and phytohemagglutinin and tuberculin-stimulated human peripheral lymphocytes.
    Papageorgiou PS; Sorokin CF; Glade PR
    J Immunol; 1974 Feb; 112(2):675-82. PubMed ID: 4591976
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro study of cellular immunity against autochthonous human cancer.
    Segall A; Weiler O; Genin J; Lacour J; Lacour F
    Int J Cancer; 1972 Mar; 9(2):417-25. PubMed ID: 4339416
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study between CEA serum levels and leukocyte migration inhibition levels in bronchial cancers].
    Gautier H; Botto HG; Pouillart P; Magdelenat H; Huguenin P; Parrot R
    Bull Cancer; 1976; 63(4):633-8. PubMed ID: 1021191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlation between immunological stage and response to chemotherapy. Results in 64 patients with nonresectable epidermoid bronchial cancers].
    Pouillart P; Botto G; Gauthier H; Huguenin P; Baron A; Laparre C; Hoang Thy HT; Parrot R; Mathé G
    Nouv Presse Med; 1976 Apr; 5(16):1037-42. PubMed ID: 1272771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts.
    Szigeti R; Timár L; Révész T
    Allergy; 1980 Mar; 35(2):97-103. PubMed ID: 6155797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.